{"id":"https://openalex.org/W118629162","doi":null,"title":"An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.","display_name":"An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W118629162","mag":"118629162","pmid":"https://pubmed.ncbi.nlm.nih.gov/22453590"},"language":"en","primary_location":{"id":"pmid:22453590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22453590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032610869","display_name":"Michael H. Gold","orcid":"https://orcid.org/0000-0002-5183-5433","observed_orcids":["https://orcid.org/0000-0002-5183-5433"]},"institutions":[{"id":"https://openalex.org/I4210156791","display_name":"Gold Skin Care Center","ror":"https://ror.org/04wga4j73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156791"]},{"id":"https://openalex.org/I4210158012","display_name":"Tennessee Clinical Research Center","ror":"https://ror.org/05jsaxg97","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210158012"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H Gold","raw_affiliation_strings":["Gold Skin Care Center and Tennessee Clinical Research Center, Nashville, TN, USA. goldskin@goldskincare.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gold Skin Care Center and Tennessee Clinical Research Center, Nashville, TN, USA. goldskin@goldskincare.com","institution_ids":["https://openalex.org/I4210156791","https://openalex.org/I4210158012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059096225","display_name":"Tancy M Bridges","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tancy Bridges","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113736752","display_name":"Edward V. Avakian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward V Avakian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056578257","display_name":"Stefan Plaum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Plaum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089682153","display_name":"Alan B. Fleischer","orcid":"https://orcid.org/0000-0001-8679-3352","observed_orcids":["https://orcid.org/0000-0001-8679-3352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan B Fleischer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109083502","display_name":"Bhushan Hardas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bhushan Hardas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3625,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.61694051,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":"4","first_page":"514","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naftifine","display_name":"naftifine","score":0.8550000190734863},{"id":"https://openalex.org/keywords/seborrheic-dermatitis","display_name":"seborrheic dermatitis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/scalp","display_name":"scalp","score":0.7820000052452087},{"id":"https://openalex.org/keywords/topical-antifungal-therapy","display_name":"topical antifungal therapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6190000176429749},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.675000011920929},{"id":"https://openalex.org/keywords/erythema","display_name":"erythema","score":0.781000018119812},{"id":"https://openalex.org/keywords/scaling","display_name":"scaling","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.8999999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9511436223983765},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.7548009753227234},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.7456576824188232},{"id":"https://openalex.org/C2779923671","wikidata":"https://www.wikidata.org/wiki/Q199602","display_name":"Itching","level":2,"score":0.730444610118866},{"id":"https://openalex.org/C2777484424","wikidata":"https://www.wikidata.org/wiki/Q448310","display_name":"Seborrheic dermatitis","level":2,"score":0.5906023383140564},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5016565322875977},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4265627861022949},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.41039949655532837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3732224106788635}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000499","descriptor_name":"Allylamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012535","descriptor_name":"Scalp","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012628","descriptor_name":"Dermatitis, Seborrheic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012628","descriptor_name":"Dermatitis, Seborrheic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22453590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22453590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Clinical Trial"},{"id":"mag:118629162","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22453590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4245518287","https://openalex.org/W2129797876","https://openalex.org/W87759831","https://openalex.org/W1985434572","https://openalex.org/W904252285","https://openalex.org/W2092759206","https://openalex.org/W2010212789","https://openalex.org/W4406150090","https://openalex.org/W2946766128","https://openalex.org/W2122042386"],"abstract_inverted_index":{"Topical":[0],"antifungal":[1],"treatment":[2,61,111,257,288],"is":[3,283],"a":[4,75],"mainstay":[5],"of":[6,36,48,62,65,78,84,122,229,236,240,242,256,292],"therapy":[7,31],"for":[8,28,56,127,186,280,289],"Seborrehic":[9],"Dermatitis":[10],"(SD).":[11],"Although":[12],"the":[13,44,66,85,94,168,187,234,254,268,293],"amidazole":[14],"and":[15,46,89,110,124,129,164,173,180,189,198,214,223,258,285],"ciclopyridine":[16],"antifungals":[17],"have":[18],"been":[19],"extensively":[20],"studied,":[21],"few":[22],"clinical":[23],"efficacy":[24,45,106,128],"data":[25,107],"are":[26],"available":[27],"topical":[29,60,287],"allylamine":[30],"in":[32,139,227],"SD.":[33],"The":[34],"objective":[35],"this":[37],"open-label":[38],"exploratory":[39],"study":[40],"was":[41,112,133],"to":[42,93],"evaluate":[43],"safety":[47,130],"natifine":[49],"HCl":[50],"1%":[51,275],"gel":[52,276],"applied":[53,277],"twice":[54,278],"daily":[55,279],"4":[57,72,91,120,222,281],"weeks,":[58],"as":[59,249],"moderate":[63,290],"SD":[64,83,146,291],"scalp.":[67,294],"Nine":[68],"subjects":[69,101,232,245],"(5":[70],"men,":[71],"women)":[73],"with":[74,82],"mean":[76],"age":[77],"56":[79],"(33-81)":[80],"years":[81],"scalp":[86],"were":[87,102,108,262],"enrolled":[88],"made":[90],"visits":[92],"site.":[95],"At":[96],"Visit":[97],"1":[98],"(Week":[99],"0),":[100],"screened,":[103],"enrolled,":[104],"baseline":[105,138,202,213,219,252],"obtained,":[109],"initiated.":[113],"Subjects":[114],"returned":[115],"at":[116,204,253],"Week":[117,119,125,205,259],"2,":[118],"(end":[121],"treatment),":[123],"6":[126],"assessments.":[131],"Efficacy":[132],"evaluated":[134],"by":[135,220,233],"changes":[136],"from":[137,200,212,218,251],"investigator-rated":[140],"scores":[141,166,185],"on":[142,167],"0-5-grade":[143],"scales:":[144],"(1)":[145],"Global":[147,175],"Evaluation":[148],"Scale":[149],"(SDGES),":[150],"(2)":[151],"Erythema":[152],"Severity":[153,157,171],"Scale,":[154,158,163,172,177],"(3)":[155],"Scaling":[156],"(4)":[159,169],"%":[160,190],"Scalp":[161,191],"Involvement":[162,192],"subject-rated":[165],"Itching":[170,225],"(5)":[174],"Improvement":[176],"where":[178],"0=none":[179],"5=most":[181],"severe.":[182],"Mean":[183,207],"severity":[184],"SDGES":[188],"scales":[193],"progressively":[194],"declined":[195],"(improved)":[196],"66%":[197],"54%":[199],"respective":[201],"levels":[203],"6.":[206,224,260],"erythema":[208],"rating":[209],"decreased":[210,216],"38%":[211],"scaling":[215],"50%":[217],"Weeks":[221],"improved":[226,250],"5":[228],"9":[230,243],"(56%)":[231],"end":[235,255],"treatment.":[237],"A":[238],"total":[239],"8":[241],"(89%)":[244],"rated":[246],"their":[247],"symptoms":[248],"There":[261],"no":[263],"treatment-related":[264],"adverse":[265],"events":[266],"during":[267],"study.":[269],"These":[270],"results":[271],"suggest":[272],"that":[273],"naftifine":[274],"weeks":[282],"effective":[284],"safe":[286]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}